Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
作者信息
Jacobs Jeremy W, Stephens Laura D, Chooljian David M, Sharma Deva, Adkins Brian D, Booth Garrett S
机构信息
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Pathology, University of California San Diego, La Jolla, California, USA.
出版信息
Am J Hematol. 2024 Jun;99(6):1016-1018. doi: 10.1002/ajh.27275. Epub 2024 Feb 26.
PMID:38409818
Abstract
摘要
Zotero 插件